Once Daily Oral Relugolix Combination Therapy Versus Placebo in Patients With Endometriosis-Associated Pain: Two Replicate Phase 3, Randomised, Double-Blind, Studies (SPIRIT 1 and 2)
- PMID: 39395815
- DOI: 10.1016/j.jogn.2024.09.009
Once Daily Oral Relugolix Combination Therapy Versus Placebo in Patients With Endometriosis-Associated Pain: Two Replicate Phase 3, Randomised, Double-Blind, Studies (SPIRIT 1 and 2)
Abstract
The author describes the results of a study to examine the effect of three treatment regimens on pain associated with endometriosis.
Copyright © 2024 AWHONN, the Association of Women’s Health, Obstetric and Neonatal Nurses. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest The author reports no conflicts of interest or relevant financial relationships.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
